Explainers
Compounded (503A) vs research-use peptides — how they differ
Search results after the 2026 compounding news often mix two different things: pharmacy compounding under section 503A, and research-use-only (RUO) vials sold as laboratory materials. This page keeps those lanes separate.
Compounded peptides (503A lane)
Under federal compounding law, a 503A compound is generally prepared by a state-licensed pharmacy (or certain other qualifying actors) for an identified patient pursuant to a prescription, using bulk substances and conditions that fit FDA/HHS rules. The October 2026 HHS interim enforcement-discretion policy describes when HHS does not intend to enforce against compounding with six named peptide bulk substances while bulks-list rulemaking continues. That policy has its own conditions (identity, manufacturing, testing, labeling, reporting, and more) in the HHS materials.
Primary: HHS appendix PDF · FR public inspection · FDA 503A bulks page.
Research-use peptides (RUO lane)
peptide.prof sells lyophilized research vials and certain disposable research pens as laboratory research material. Pages state research use only, not for human or veterinary use, and the store does not provide dose or administration instructions. Payment is to peptide.prof; shipping is to a United States address after payment. That is a materials purchase for research workflows — not a compounded drug product and not a pharmacy prescription fill.
See research use and the live catalog.
Why the distinction matters for buyers
- Different legal frames — compounding policy text does not rewrite RUO retail labeling.
- Different documents — a compounded label (“This is a compounded drug product…”) is not what an RUO vial page claims.
- Different stock systems — peptide.prof stock follows supplier/Lotus live inventory for listed SKUs; pharmacy compounding inventory is unrelated.
Named in the 2026 HHS six-peptide set and listed here as research vials where supply exists:
MOTS-c · KPV · BPC-157 · TB-500 · Semax · Epitalon (price pending)
FAQ
- Does peptide.prof compound under 503A?
- No. peptide.prof sells laboratory research materials only. It is not presenting itself as a 503A compounding pharmacy under the HHS interim policy.
- Can I treat an RUO vial like a compounded drug?
- No. Research-use labeling means laboratory research material, not for human or veterinary use. This site does not provide dosing or administration instructions.
- Where do I read the official HHS policy?
- Start with the HHS appendix PDF and the Federal Register public inspection notice linked in the compounding tracker on this site.
Research use only. Not for human or veterinary use. No dose or administration instructions on this site. peptide.prof does not compound under section 503A or 503B.